Summer 2019 has come and gone, and your attention is set on fantasy football! That means it’s time for a quarterly update from NuVasive Clinical Services (NCS). Today we’re giving you the scoop on new tools for increasing OR efficiency and spotlighting how less invasive surgery changed the life of a NFL Hall of Fame running back. Hint: “The Bus”.

New tech + tools for your OR

NuVasive recently announced the commercial launch of Pulse, an integrated technology platform to enable better spine surgery. In a single expandable platform, Pulse integrates multiple enabling technologies to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. These technologies include neuromonitoring, global alignment, rod bending, radiation reduction, imaging, navigation, robotics, smart tools and other applications. Learn more.

NCS joins the conversation at ASNM Fall Symposium
NCS was proud to participate in this year’s American Society of Neurophysiological Monitoring (ASNM) Fall Symposium hosted in Boston, MA on September 13-15. The event focused on advanced methods for monitoring and mapping the nervous system. With NCS’ own Dr. Rich Vogel as ASNM President, the society has emerged as the nation’s premier resource for IOM education. Read more.

Welcoming a new biologicPropel DBM Sponge
Propel DBM Sponge is a unique form of partially demineralized bone matrix, consisting of 100% cancellous bone with no carrier. It is engineered as a single piece of bone for handling and ease of use. Following hydration, Propel DBM Sponge is able to fill, compress, and conform to a variety of bony voids and accommodate difficult anatomy. It provides a natural osteoconductive scaffold and osteoinductive signaling properties to support new bone growth.1 Learn more.

Industry spotlight

After his life-changing XLIF procedure, Jerome ‘The Bus’ Bettis becomes a NuVasive brand ambassador.

Learn more about NuVasive’s porous titanium spine implant engineered for the TLIF procedure.

Click the boxes to read each article.

Food for thought
How to optimize neuromonitoring: “does neuromonitoring add time to your surgery?” A podcast by the NASS IOM section, chaired by Drs. Adam Doan and Richard Vogel
In this episode, Adam and Rich discuss how IOM may sometimes add time to surgery, but a closer look will show that it is negligible if the IOM team can work efficiently and in collaboration with the rest of the patient care team in the OR.

Meet our team
Meet Kristyn
Sr. Neurophysiologist, Massachusetts North/New Hampshire.

The best part of my job is having the ability to cultivate my voice and the voice of my patients, who are at times unable to appropriately advocate for themselves. I also love collaborating with hospital staff as they manage in-patient care, helping play a role in improving postoperative outcomes.Hear more from the NCS team at #MeetTheNP.

To see the Q2 NCS newsletter, click here.
* Certain applications of the Pulse platform are under development and not available for commercial sales; robotics and smart tools are not cleared for use by the FDA.

1. Shi Y, Dittman B, Atkinson B, et al. Bone morphogenetic protein (BMP) content in cancellous bone: A suitable substrate for allograft stem cells. AlloSource White Paper, 2011.
Previous PostNext Post